Advanced search
Publication Cover
Expert Review of Gastroenterology & Hepatology Volume 1, 2007 - Issue 1
Submit an article Journal homepage
84
Views
7
CrossRef citations to date
0
Altmetric
Drug Profile

Natalizumab: pharmacology, clinical efficacy and safety in the treatment of patients with Crohn’s disease

Hin Hin Ko Gastroenterology Resident, University of British Columbia, Division of Gastroenterology, 770–1190 Hornby Street, Vancouver, BC V6Z 2K5, Canada
&
Brian Bressler Clinical Instructor, University of British Columbia, Division of Gastroenterology, 770–1190 Hornby Street, Vancouver, BC V6Z 2K5, Canada. [email protected]
Pages 29-39 | Published online: 10 Jan 2014

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Zachary A. Borman, Justin Côté-Daigneault & Jean-Frédéric Colombel. (2018) The risk for opportunistic infections in inflammatory bowel disease with biologics: an update. Expert Review of Gastroenterology & Hepatology 12:11, pages 1101-1108.
Read now
Javier P. Gisbert & María Chaparro. (2015) Use of a third anti-TNF after failure of two previous anti-TNFs in patients with inflammatory bowel disease: is it worth it?. Scandinavian Journal of Gastroenterology 50:4, pages 379-386.
Read now
Kylie Thaler, Divya V Chandiramani, Richard A Hansen & Gerald Gartlehner. (2009) Efficacy and safety of anakinra for the treatment of rheumatoid arthritis: an update of the Oregon Drug Effectiveness Review Project. Biologics: Targets and Therapy 3, pages 485-498.
Read now
Joseph R. Berger, Sidney A. Houff & Eugene O. Major. (2009) Monoclonal antibodies and progressive multifocal leukoencephalopathy. mAbs 1:6, pages 583-589.
Read now

Articles from other publishers (3)

Marek Vebr, Renáta Pomahačová, Josef Sýkora & Jan Schwarz. (2023) A Narrative Review of Cytokine Networks: Pathophysiological and Therapeutic Implications for Inflammatory Bowel Disease Pathogenesis. Biomedicines 11:12, pages 3229.
Crossref
Xiaocong Pang, Xu He, Zhiwei Qiu, Hanxu Zhang, Ran Xie, Zhiyan Liu, Yanlun Gu, Nan Zhao, Qian Xiang & Yimin Cui. (2023) Targeting integrin pathways: mechanisms and advances in therapy. Signal Transduction and Targeted Therapy 8:1.
Crossref
Andreas Stallmach, Stefan Hagel & Tony Bruns. (2010) Adverse effects of biologics used for treating IBD. Best Practice & Research Clinical Gastroenterology 24:2, pages 167-182.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.